Applications and biomonitoring issues of recombinant erythropoietins for doping control.
about
Erythropoietin and mTOR: A "One-Two Punch" for Aging-Related Disorders Accompanied by Enhanced Life ExpectancyRed blood cell populations and membrane levels of peroxiredoxin 2 as candidate biomarkers to reveal blood doping.Comparable pharmacokinetics and pharmacodynamics of two epoetin alfa formulations Eporon® and Eprex® following a single subcutaneous administration in healthy male volunteers.Effects of erythropoietin abuse on exercise performance.Surface-enhanced Raman probe for rapid nanoextraction and detection of erythropoietin in urine.
P2860
Applications and biomonitoring issues of recombinant erythropoietins for doping control.
description
2011 nî lūn-bûn
@nan
2011 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
name
Applications and biomonitoring issues of recombinant erythropoietins for doping control.
@ast
Applications and biomonitoring issues of recombinant erythropoietins for doping control.
@en
type
label
Applications and biomonitoring issues of recombinant erythropoietins for doping control.
@ast
Applications and biomonitoring issues of recombinant erythropoietins for doping control.
@en
prefLabel
Applications and biomonitoring issues of recombinant erythropoietins for doping control.
@ast
Applications and biomonitoring issues of recombinant erythropoietins for doping control.
@en
P2093
P1476
Applications and biomonitoring issues of recombinant erythropoietins for doping control.
@en
P2093
Christina Tsitsimpikou
Demetrios Kouretas
Kenneth Fitch
Konstantinos Tsarouhas
P356
10.1097/FTD.0B013E31820032C4
P577
2011-02-01T00:00:00Z